FDA to Review Diroximel Fumarate for Treatment of Relapsing Forms of MS - Neurology Advisor https://t.co/94ZW80x2hh
— IDRO (@IDROOhio) February 28, 2019
from Twitter https://twitter.com/IDROOhio
February 28, 2019 at 04:32AM
Thursday, February 28, 2019
FDA to Review Diroximel Fumarate for Treatment of Relapsing Forms of MS - Neurology Advisor https://t.co/94ZW80x2hh
from Twitter https://twitter.com/IDROOhio
February 28, 2019 at 04:32AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment